GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Syncom Formulation (India) Ltd (NSE:SYNCOMF) » Definitions » EV-to-FCF

Syncom Formulation (India) (NSE:SYNCOMF) EV-to-FCF : (As of May. 11, 2024)


View and export this data going back to 2022. Start your Free Trial

What is Syncom Formulation (India) EV-to-FCF?

EV-to-FCF is calculated as enterprise value divided by its free cash flow. As of today, Syncom Formulation (India)'s Enterprise Value is ₹12,454 Mil. Syncom Formulation (India)'s Free Cash Flow for the trailing twelve months (TTM) ended in Dec. 2023 was ₹0 Mil. Therefore, Syncom Formulation (India)'s EV-to-FCF for today is .

The historical rank and industry rank for Syncom Formulation (India)'s EV-to-FCF or its related term are showing as below:

NSE:SYNCOMF' s EV-to-FCF Range Over the Past 10 Years
Min: -149.94   Med: 0   Max: 0
Current: -131.61

NSE:SYNCOMF's EV-to-FCF is ranked worse than
100% of 511 companies
in the Drug Manufacturers industry
Industry Median: 23.55 vs NSE:SYNCOMF: -131.61

EV-to-FCF is a valuation multiple that allows analysts and investors to compare stocks, preferably in the same sector or industry. This important multiple is often used in conjunction with, or as an alternative to, the PE Ratio to determine the fair market value of a company.

As of today (2024-05-11), Syncom Formulation (India)'s stock price is ₹13.05. Syncom Formulation (India)'s Earnings per Share (Diluted) for the trailing twelve months (TTM) ended in Dec. 2023 was ₹0.340. Therefore, Syncom Formulation (India)'s PE Ratio for today is 38.38.


Syncom Formulation (India) EV-to-FCF Historical Data

The historical data trend for Syncom Formulation (India)'s EV-to-FCF can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Syncom Formulation (India) EV-to-FCF Chart

Syncom Formulation (India) Annual Data
Trend Mar14 Mar15 Mar16 Mar17 Mar18 Mar19 Mar20 Mar21 Mar22 Mar23
EV-to-FCF
Get a 7-Day Free Trial Premium Member Only Premium Member Only 19.69 12.13 -49.37 186.27 -56.11

Syncom Formulation (India) Quarterly Data
Mar19 Jun19 Sep19 Dec19 Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23
EV-to-FCF Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only - -56.11 - - -

Competitive Comparison of Syncom Formulation (India)'s EV-to-FCF

For the Drug Manufacturers - Specialty & Generic subindustry, Syncom Formulation (India)'s EV-to-FCF, along with its competitors' market caps and EV-to-FCF data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Syncom Formulation (India)'s EV-to-FCF Distribution in the Drug Manufacturers Industry

For the Drug Manufacturers industry and Healthcare sector, Syncom Formulation (India)'s EV-to-FCF distribution charts can be found below:

* The bar in red indicates where Syncom Formulation (India)'s EV-to-FCF falls into.



Syncom Formulation (India) EV-to-FCF Calculation

Syncom Formulation (India)'s EV-to-FCF for today is calculated as:

EV-to-FCF=Enterprise Value (Today)/Free Cash Flow (TTM)
=12454.009/0
=

Syncom Formulation (India)'s current Enterprise Value is ₹12,454 Mil.
Syncom Formulation (India)'s Free Cash Flow for the trailing twelve months (TTM) ended in Dec. 2023 adds up the quarterly data reported by the company within the most recent 12 months, which was ₹0 Mil.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


Syncom Formulation (India)  (NSE:SYNCOMF) EV-to-FCF Explanation

EV-to-FCF is a valuation multiple that allows analysts and investors to compare stocks, preferably in the same sector or industry. This important multiple is often used in conjunction with, or as an alternative to, the PE Ratio to determine the fair market value of a company.

Syncom Formulation (India)'s PE Ratio for today is calculated as:

PE Ratio=Share Price (Today)/Earnings per Share (Diluted) (TTM)
=13.05/0.340
=38.38

Syncom Formulation (India)'s share price for today is ₹13.05.
Syncom Formulation (India)'s Earnings per Share (Diluted) for the trailing twelve months (TTM) ended in Dec. 2023 adds up the quarterly data reported by the company within the most recent 12 months, which was ₹0.340.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Enterprise Value is used because it is a more complete measure in reflecting how much an investor pays when buying a company. Free Cash Flow is an important financial metric because it represents the actual amount of cash at a company's disposal. Companies with a low EV-to-FCF ratio, combined with a strong balance sheet are generally considered as undervalued.


Syncom Formulation (India) EV-to-FCF Related Terms

Thank you for viewing the detailed overview of Syncom Formulation (India)'s EV-to-FCF provided by GuruFocus.com. Please click on the following links to see related term pages.


Syncom Formulation (India) (NSE:SYNCOMF) Business Description

Traded in Other Exchanges
Address
207, Saket Nagar, Near Saket Club, Indore, MP, IND, 452018
Syncom Formulation (India) Ltd is in the business of pharmaceuticals. The company operates through three segments including manufacturing and dealings in Pharmaceutical drugs and formulations, Trading of commodities, and Renting of property. It manufactures and markets pharmaceutical formulation products in various dosage forms like tablets, capsules, liquids orals, liquids vials, ampoule injections and dry vial injections, dry syrups, ointments, inhalers, and Herbals. The company's product includes generic, antiviral, antidepressant, cough suppressant, electrolyte, histamine, estrogen, and much more. It generates maximum revenue through the Pharmaceutical drugs and formulations segment.

Syncom Formulation (India) (NSE:SYNCOMF) Headlines

No Headlines